Deprescribing and Polypharmacy in an Aging Population
Autor: | Ali Elbeddini |
---|---|
EAN: | 9780323993814 |
eBook Format: | PDF/ePUB |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 22.08.2023 |
Kategorie: | |
Schlagworte: | AI Alzheimer&rsquo Artificial Intelligence Drug safety deprescribing geriatric polypharmacy s |
155,00 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population. - Emphasizes the importance of involving a multidisciplinary team in deprescribing efforts - Identifies barriers and enablers for the implementation of deprescribing programs - Develops strategies to address barriers and optimize enablers for deprescribing implementation
Dr. Elbeddini is Affiliate Investigator in Epidemiology at Ottawa Hospital Research Institute (OHRI), Canada. He previously an Assistant Professor in Clinical Pharmacy at Skaggs School of Pharmacy, University of Colorado, USA and conducted post-doctorate research at Harvard Medical School (HMS) in Global Clinical Scholars Research Education program.
Dr. Elbeddini is Affiliate Investigator in Epidemiology at Ottawa Hospital Research Institute (OHRI), Canada. He previously an Assistant Professor in Clinical Pharmacy at Skaggs School of Pharmacy, University of Colorado, USA and conducted post-doctorate research at Harvard Medical School (HMS) in Global Clinical Scholars Research Education program.